Scott Rocklage
InvestorFounding Partner at 5AM Ventures · Board director at Expansion Therapeutics · Board director at Cidara Therapeutics · Board director at Kinestral Technologies
Palm Beach Gardens, Florida
Writes $100K – $5M checks · typically $1.5M
About
Scott Rocklage, MIT PhD chemist (Schrock lab) and ex-CEO of Cubist and Nycomed Salutar, combines operator experience, a global US/Europe/Asia board footprint, and partners with technical founders to shape medicines.
Contact· published on Scott's own website
Invests in
BiotechHealthtechMedical Devices
Board director at Expansion Therapeutics
Intro paths
In turn, Scott can intro founders to Expansion Therapeutics's investors below.
Expansion Therapeutics's investors · 4
Co-founders at Expansion Therapeutics
Board director at Cidara Therapeutics
Intro paths
In turn, Scott can intro founders to Cidara Therapeutics's investors below.
Cidara Therapeutics's investors · 8
Co-founders at Cidara Therapeutics
Board director at Kinestral Technologies
Intro paths
In turn, Scott can intro founders to Kinestral Technologies's investors below.
Kinestral Technologies's investors · 2
Experience
- 5AM VenturesFounding Partnercurrent2018 — present
Deals · 5
Kinestral TechnologiesBoard seat
via 5AM Ventures · filed Jun 2018 · $54.6M raise
Cidara TherapeuticsBoard seat
via 5AM Ventures · filed Oct 2017 · $20.2M raise
RennoviaBoard seat
via 5AM Ventures · filed Feb 2017 · $6M raise
PulmatrixBoard seat
via 5AM Ventures · filed Jun 2015 · $210K raise
Pulmatrix OperatingBoard seat
via 5AM Ventures · filed Jun 2015 · $34.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at 5AM Ventures
Network1
Investors connected to Scott in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Scott Rocklage?
- Scott Rocklage, MIT PhD chemist (Schrock lab) and ex-CEO of Cubist and Nycomed Salutar, combines operator experience, a global US/Europe/Asia board footprint, and partners with technical founders to shape medicines.
- Where does Scott Rocklage work?
- Scott Rocklage is Founding Partner at 5AM Ventures and Board director at Expansion Therapeutics and Board director at Cidara Therapeutics and Board director at Kinestral Technologies.
- What does Scott Rocklage invest in?
- Scott Rocklage invests in Biotech, Healthtech, Medical Devices.
- What check size does Scott Rocklage write?
- Scott Rocklage typically writes checks of $100K – $5M.
- What boards does Scott Rocklage sit on?
- Scott Rocklage holds tracked board seats at Cidara Therapeutics, Kinestral Technologies, Pulmatrix, Pulmatrix Operating, Rennovia.
- Where did Scott Rocklage go to school?
- Scott Rocklage studied at Massachusetts Institute of Technology (Doctor of Philosophy - PhD, Chemistry); U.C. Berkeley.
Same school
Also attended Massachusetts Institute of Technology1,387
+ 1,381 more